Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

HKBU-led Research Team Develops Anti-viral Targeted Drug for Nasopharyngeal Cancer Treatment

americanpharmaceuticalreviewMay 18, 2020

Tag: Nasopharyngeal Cancer , HKBU , EBV

PharmaSources Customer Service